Oncology & Cancer

Prostate cancer screening declined following 2012 USPSTF guidance

(HealthDay)—There were large temporal changes in screening, biopsy, overall cancer detection, and metastatic cancer rates following the 2012 U.S. Preventive Services Task Force (USPSTF) Prostate Cancer Screening Statement, ...

Oncology & Cancer

PSA testing rates up in the U.S. after change in guidance

(HealthDay)—Rates of prostate-specific antigen (PSA) testing increased significantly after the 2017 U.S. Preventive Services Task Force (USPSTF) draft statement on prostate cancer screening, reversing trends that resulted ...

Oncology & Cancer

50 years on, real progress in war against cancer

Since 1971, when the U.S. government made defeating cancer a goal and put major funding behind it, death rates for many cancers have plummeted, but some are increasing, according to a new American Cancer Society report.

Oncology & Cancer

Prostate cancer risks in African American men

Prostate cancer, the second-most common cancer in men behind skin cancer with nearly a quarter of a million cases in the U.S. diagnosed annually, plays favorites.

Oncology & Cancer

Mayo Clinic Minute: Understanding lung cancer

Lung cancer is the leading cause of cancer deaths worldwide. Each year, more people die from lung cancer than colon, breast and prostate cancers combined, according to the American Cancer Society.

Oncology & Cancer

Importance of preventive health care during COVID-19 pandemic

Preventive health care helps you maintain your health. Screenings are important to avoid future health problems or catch them early when they are easier to treat. But the COVID-19 pandemic has led to a decrease in preventive ...

Oncology & Cancer

More prostate cancers are being diagnosed at a later stage

(HealthDay)—While men can take solace in a new government report that shows prostate cancer cases have been declining overall in the past two decades, the same analysis finds that the opposite is true for advanced prostate ...

page 2 from 10